Carregant...
Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
Sildenafil is a phosphodiesterase type-5 inhibitor approved for treatment of pulmonary arterial hypertension (PAH) in adults. Data from pediatric trials demonstrate a similar acute safety profile to the adult population but have raised concerns regarding the safety of long-term use in children. Inte...
Guardat en:
| Publicat a: | Drug Healthc Patient Saf |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687613/ https://ncbi.nlm.nih.gov/pubmed/26719728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S65571 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|